High prevalence of viral hepatitis in a series of splenic marginal zone lymphomas from Romania

B Fetica¹, B Pop^{1

2}, M L Blaga³, A Fulop¹, D Dima⁴, M T Zdrenghea^{4

5}, C I Vlad^{6

7}, A S Bojan^{4

5}, P Achimas-Cadariu^{6

7}, C I Lisencu^{6

7}, A Irimie^{6

7}, D D Weisenburger⁸

Affiliations

¹ Department of Pathology, The Oncology Institute 'Prof. dr. I. Chiricuta', Cluj-Napoca, Romania.
² Department of Pathology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania.
³ Department of Epidemiology and Biostatistics, The Oncology Institute 'Prof. dr. I. Chiricuta', Cluj-Napoca, Romania.
⁴ Department of Hematology, The Oncology Institute 'Prof. dr. I. Chiricuta', Cluj-Napoca, Romania.
⁵ Department of Hematology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania.
⁶ Department of Surgery, The Oncology Institute 'Prof. dr. I. Chiricuta', Cluj-Napoca, Romania.
⁷ Department of Surgery and Gynecologic Oncology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania.
⁸ Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA.

B Fetica et al. Blood Cancer J. 2016.

. 2016 Nov 11;6(11):e498.

doi: 10.1038/bcj.2016.102.

¹ Department of Pathology, The Oncology Institute 'Prof. dr. I. Chiricuta', Cluj-Napoca, Romania.
² Department of Pathology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania.
³ Department of Epidemiology and Biostatistics, The Oncology Institute 'Prof. dr. I. Chiricuta', Cluj-Napoca, Romania.
⁴ Department of Hematology, The Oncology Institute 'Prof. dr. I. Chiricuta', Cluj-Napoca, Romania.
⁵ Department of Hematology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania.
⁶ Department of Surgery, The Oncology Institute 'Prof. dr. I. Chiricuta', Cluj-Napoca, Romania.
⁷ Department of Surgery and Gynecologic Oncology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania.
⁸ Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA.

No abstract available

Figures

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et alWHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC): Lyon, France, 2008, 439.
1. Perrone S, D'Elia GM, Annechini G, Pulsoni A. Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy. Mediterr J Hematol Infect Dis 2016; 8: e2016006. - PMC - PubMed
1. Arcaini L, Burcheri S, Rossi A, Paulli M, Bruno R, Passamonti F et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol 2007; 18: 346–350. - PubMed
1. ECDC. Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies. Technical Report. 2010. European Centre for Disease Prevention and Control: Stockholm, Sweden.
1. Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Smira G, Regep L. The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006 - 2008. J Gastrointestin Liver Dis 2010; 19: 373–379. - PubMed